Chowdhury B, Luu AZ, Luu VZ, Kabir MG, et al. The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension. Biochem Biophys Res Commun 2020 Jan 21. pii: S0006-291X(20)30034.
PMID: 31980166